According to BioLineRx's latest financial reports the company's current EPS (TTM) is -$1.42. In 2022 the company made an earnings per share (EPS) of -$0.71 an increase over its 2021 EPS that were of -$0.94.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.37 | 93.87% |
2022 | -$0.71 | -25% |
2021 | -$0.94 | -66.67% |
2020 | -$2.83 | -29.41% |
2019 | -$4.01 | -19.05% |
2018 | -$4.96 | -22.22% |
2017 | -$6.38 | -3.57% |
2016 | -$6.61 | -0% |
2015 | -$6.61 | -17.65% |
2014 | -$8.03 | -55.26% |
2013 | -$17.95 | -36.9% |
2012 | -$28.45 | 11.81% |
2011 | -$25.44 | -737.01% |
2010 | $3.99 |